The trinity of COVID-19: immunity, inflammation and intervention.

Nature Reviews Immunology.  28 april 2020

COVID-19 vaccine design: the Janus face of immune enhancement

Nature Reviews Immunology.  28 april 2020

Complement as a target in COVID-19?

Nature Reviews Immunology.  23 april 2020

COVID-19: risk for cytokine targeting in chronic inflammatory diseases?

Nature Reviews Immunology 2020;20(may):271-272

The potential danger of suboptimal antibody responses in COVID-19.

Nature Reviews Immunology.  21 april 2020

COVID-19: immunopathology and its implications for therapy.

Nat Rev Immunol. 2020 Apr 9.

Is antibody-dependent enhancement playing a role in COVID-19 pathogenesis?

Swiss Med Wkly. 2020 Apr 16;150:w20249.

Antibody responses to SARS-CoV-2 in patients of novel coronavirus disease 2019.

Clin Infect Dis. 2020 Mar 28. pii: ciaa344.

Coronavirus infections: Epidemiological, clinical and immunological features and hypotheses

Cell Stress. 2020 Mar 2;4(4):66-75

COVID-19 infection: the perspectives on immune responses

Cell Death Differ. 2020 May;27(5):1451-1454.

Cytokine release syndrome in severe COVID-19.

Science. 2020 Apr 17. pii: eabb8925.

COVID-19: consider cytokine storm syndromes and immunosuppression.

Lancet. 2020 Mar 28;395(10229):1033-1034.

On the alert for cytokine storm: Immunopathology in COVID-19.

Arthritis Rheumatol. 2020 Apr 15.

Dysregulation of immune response in patients with COVID-19 in Wuhan, China.

Clin Infect Dis. 2020 Mar 12. pii: ciaa248.

Harnessing Innate Immunity to Eliminate SARS-CoV-2 and Ameliorate COVID-19 Disease.

Physiol Genomics. 2020 Apr 10

COVID-19: Herd Immunity and Convalescent Plasma Transfer Therapy.

J Med Virol. 2020 Apr 13.

Immune-epidemiological parameters of the novel coronavirus – a perspective.

Expert Rev Clin Immunol. 2020; 0(0): 1–6.

Immune phenotyping based on neutrophil-to-lymphocyte ratio and IgG predicts disease severity and outcome for patients with COVID-19.


Breadth of concomitant immune responses prior to patient recovery: a case report of non-severe COVID-19.

Nat Med. 2020 Apr;26(4):453-455.

Innate Immune Evasion by Human Respiratory RNA Viruses.

J Innate Immun. 2020;12(1):4-20.

Molecular Mechanism for Antibody-Dependent Enhancement of Coronavirus Entry.

J Virol. 2020 Feb 14;94(5).

Neutralization of SARS-CoV-2 spike pseudotyped virus by recombinant ACE2-Ig.

Nature Communications volume 11, Article number: 2070 (2020)

SARS-CoV-2 infects T lymphocytes through its spike protein-mediated membrane fusion.

Cell Mol Immunol. 2020 Apr 7

Targeting the Adipose Tissue in COVID-19.

Obesity (Silver Spring). 2020 Apr 21.

The Potential Role of Th17 Immune Responses in Coronavirus Immunopathology and Vaccine-induced Immune Enhancement.

Microbes Infect. 2020 Apr 16. pii: S1286-4579(20)30072-1

Comentarios desactivados en INMUNIDAD Y SARS CoV2